SCHEMBL2853508

SCHEMBL2853508

CC(C)Oc1ccc(NC(=O)[C@@H]2CCC[C@@H](Sc3ccccn3)C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELOVL6 Q9H5J4 5/20 0.47
RAB9A P51151 4/20 0.43
NPC1 O15118 2/20 0.43
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 2/20 0.42
ADRB2 P07550 1/20 0.42
TSHR P16473 1/20 0.42
HTT P42858 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
TP53 P04637 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
LMNA P02545 2/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 1/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
ABL1 P00519 1/20 0.40
GRM5 P41594 1/20 0.39
GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2853507 1.00 ELOVL6 (0.47) ELOVL6RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL711630 0.85 TP53 (0.46) ELOVL6ALDH1A1TP53SMN1; SMN2LMNA
SCHEMBL2852313 0.78 ELOVL6 (0.56) ELOVL6RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL2852312 0.78 ELOVL6 (0.56) ELOVL6RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL2847008 0.77 ELOVL6 (0.49) ELOVL6RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL2847007 0.77 ELOVL6 (0.49) ELOVL6RAB9ANPC1ALDH1A1HSD17B10
SCHEMBL710906 0.77 ALDH1A1 (0.41) RAB9ANPC1ALDH1A1TP53SMN1; SMN2
SCHEMBL2847523 0.77 ABL1 (0.47) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL2847527 0.77 ABL1 (0.47) RAB9ANPC1ALDH1A1SMN1; SMN2MEN1
SCHEMBL712394 0.76 ELOVL6 (0.52) ELOVL6RAB9ANPC1ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2236494-B1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD KK (JP) 2016-08-31 EP disclosed
EP-2236494-A1 SULFONYL SUBSTITUTED 6-MEMBERED RING DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-10-06 EP disclosed
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE MSD K.K. (JP) 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249147-A1 SULFONYL-SUBSTITUTED 6-MEMBERED RING DERIVATIVE CHRM2, CHRM3, CHRM1 ELOVL6 3399/4885RAB9A 2414/4885NPC1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.